Tarantini Giuseppe, Fabris Tommaso
Department of Cardiac, Thoracic, Vascular Sciences, University of Padua, Padua, Italy.
Catheter Cardiovasc Interv. 2020 Mar 1;95(4):817-818. doi: 10.1002/ccd.28787.
Surgical treatment is the gold standard for pure aortic regurgitation (AR). In this study, transcatheter aortic valve replacement (TAVR) appears to be a promising option for inoperable/high-risk patients suffering pure AR. Long-term results and specific patient-level data are needed to better clarify the role of TAVR in pure AR treatment.
手术治疗是单纯主动脉瓣反流(AR)的金标准。在本研究中,经导管主动脉瓣置换术(TAVR)对于患有单纯AR的无法手术/高风险患者似乎是一个有前景的选择。需要长期结果和特定患者层面的数据来更好地阐明TAVR在单纯AR治疗中的作用。